Sustained attention deficits among HIV-positive individuals with comorbid bipolar disorder

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 24, Issue 1, 2012, Pages 61-70

  Posada, Carolina ^a   Moore, David J ^b   Deutsch, Reena ^b   Rooney, Alexandra ^b   Gouaux, Ben ^b   Letendre, Scott ^b,c   Grant, Igor ^b   Hampton Atkinson, J ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MANIA; MOOD; PERFORMANCE; PRIORITY JOURNAL; REACTION TIME; SCORING SYSTEM;

EID: 84858713642     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11010028     Document Type: Article

References (51)

1. Essock SM, Dowden S, Constantine NT, et al: Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. Psychiatr Serv 2003; 54:836-841
2. Goldberg RW, Himelhoch S, Kreyenbuhl J, et al: Predictors of HIV and hepatitis testing and related service utilization among individuals with serious mental illness. Psychosomatics 2005; 46:573-577
3. Rosenberg SD, Goodman LA, Osher FC, et al: Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001; 91:31-37
4. Cournos F, McKinnon K: HIV seroprevalence among people with severe mental illness in the United States: a critical review. Clin Psychol Rev 1997; 17:259-269
5. Cruess DG, Evans DL, Repetto MJ, et al: Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biol Psychiatry 2003; 54:307-316
6. Walkup J, Crystal S, Sambamoorthi U: Schizophrenia and major affective disorder among Medicaid recipients with HIVAIDS in New Jersey. Am J Public Health 1999; 89:1101-1103
7. Beyer J, Kuchibhatla M, Gersing K, et al: Medical comor bidity in a bipolar outpatient clinical population. Neuropsychopharmacology 2005; 30:401-404
8. Heaton RK, Clifford DB, Franklin DR Jr, et al: HIV-associated neuro cognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010; 75:2087-2096
9. Hinkin CH, Castellon SA, Hardy DJ: Dual task performance in HIV-1 infection. J Clin Exp Neuropsychol 2000; 22:16-24
10. Heaton RK, Franklin DR Jr, Ellis RJ, et al: HIV-associated neurocognitive disorders before and during the era of combinationantiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011; 17:3-16
11. Heaton RK, Grant I, Butters N, et al: The HNRC 500 neuropsychology of HIV infection at different disease stages: HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1995; 1:231-251
12. Reger M, Welsh R, Razani J, et al: A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc 2002; 8:410-424
13. Grant RM, Wiley JA, Winkelstein W: Infectivity of the human immunodeficiency virus: estimates from a prospective study of homosexual men. J Infect Dis 1987; 156:189-193
14. Martin HP: Mild cognitive impairment in HIV disease. Nurse Pract 1995; 20: 94-97
15. Hinkin CH, Castellon SA, Hardy DJ, et al: Computerized and traditional Stroop task dysfunction in HIV-1 infection. Neuropsychology 1999; 13:306-316
16. Levine AJ, Hardy DJ, Miller E, et al: The effect of recent stimulant use on sustained attention in HIV-infected adults. J Clin Exp Neuropsychol 2006; 28:29-42
17. Bearden CE, Hoffman KM, Cannon TD: The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord 2001; 3:106-150; discussion, 151-153
18. Quraishi S, Frangou S: Neuropsychology of bipolar disorder: a review. J Affect Disord 2002; 72:209-226
19. Malhi GS, Ivanovski B, Hadzi-Pavlovic D, et al: Neuropsychological deficits and functional impairment in bipolar depression, hypomania, and euthymia. Bipolar Disord 2007; 9:114-125
20. Martinez-Arán A, Vieta E, Reinares M, et al: Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 161:262-270
21. Murphy FC, Rubensztein JS, Michael A, et al: Decision-making cognition in mania and depression. Psychol Med 2001;31:679-693
22. Robinson LJ, Thompson JM, Gallagher P, et al: A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006; 93(1-3):105-115
23. Torres IJ, Boudreau VG, Yatham LN: Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl 2007(434):17-26
24. Altshuler LL, Ventura J, van Gorp WG, et al: Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry 2004; 56:560-56925.
25. Balanzá-Martinez V, Tabares-Seisdedos R, Selva-Vera G, et al: Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study. Psychother Psychosom 2005; 74:113-119
26. Clark L, Goodwin GM: State- and trait-related deficits in sustained attention in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2004; 254:61-68
27. Clark L, Iversen SD, Goodwin GM: Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002; 180:313-319
28. Fleck DE, Shear PK, Strakowski SM: Processing efficiency and sustained attention in bipolar disorder. J Int Neuropsychol Soc 2005; 11:49-57
29. Harmer CJ, Clark L, Grayson L, et al: Sustained attentiondeficit in bipolar disorder is not a working memory impairment in disguise. Neuropsychologia 2002; 40:1586-1590
30. Martinez-Arán A, Vieta E, Colom F, et al: Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord 2004; 6:224-232
31. Strakowski SM, Adler CM, Holland SK, et al: A preliminary fMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacology 2004; 29:1734-1740
32. Swann AC, Pazzaglia P, Nicholls A, et al: Impulsivity and phase of illness in bipolar disorder. J Affect Disord 2003; 73(1,2):105-111
33. Thompson JM, Gallagher P, Hughes JH, et al: Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005; 186:32-40
34. Parasuraman R: Sustained attention, in Varieties of Attention. Edited by Parasuraman R, Davies DR. Orlando, FL, Academic Press, 1984
35. Braver TS, Bongiolatti SR: The role of fronto-polar cortex in sub-goal processing during working memory. Neuroimage 2002; 15:523-536
36. Karlsen NR, Reinvang I, Froland SS: Slowed reaction time in asymptomatic HIV-positive patients. Acta Neurol Scand 1992; 86:242-246
37. Damos DL, John RS, Parker ES, et al: Cognitive function in asymptomatic HIV infection. Arch Neurol 1997; 54:179-185
38. Ettenhofer ML, Foley J, Behdin N, et al: Reaction-time variability in HIV-positive individuals. Arch Clin Neuropsychol 2010; 25:791-798
39. Bora E, Vahip S, Akdeniz F: Sustained attention deficits in manic and euthymic patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:1097-1102
40. Liu SK, Chiu CH, Chang CJ, et al: Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers. Am J Psychiatry 2002; 159:975-982
41. Bozikas VP, Andreou C, Giannakou M, et al: Deficits in sustained attention in schizophrenia but not in bipolar disorder. Schizophr Res 2005; 78(2,3):225-233
42. Robertson HA, Kutcher SP, Lagace DC: No evidence of attentional deficits in stabilized bipolar youth relative to unipolar and control comparators. Bipolar Disord 2003; 5:330-339
43. Conners CK: Conners' Continuous Performance Test (CPT-II) Computer Program for Windows: Technical Guide and Software Manual. Tonawanda, NY, Multi-Health Systems, Inc., 2000
44. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC, American Psychiatric Association, 1994
45. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for DSM-IV Axis I Disorders: Clinician Version: Administration Booklet. Washington, DC, American Psychiatric Association, 1997
46. Young RC, Biggs JT, Ziegler VE, et al: A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978; 133: 429-435
47. Beck AT, Steer RA, Ball R, et al: Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess 1996; 67:588-597
48. World Health Organization: Composite International Diagnostic Interview. Geneva, Switzerland, World Health Organization, 1997
49. Tucha O, Mecklinger L, Laufkötter R, et al: Methylphenidate induced improvements of various measures of attention in adults with attention-deficit hyperactivity disorder. J Neural Transm 2006; 113:1575-1592
50. Good KP, Kiss I, Buiteman C, et al: Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetia pine: an interim analysis. Br J Psychiatry Suppl 2002; 43:S45-S49
51. Wingen M, Kuypers KP, van de Ven V, et al: Sustained attention and serotonin: a pharmaco-fMRI study. Hum Psychopharmacol 2008; 23:221-230